AstraZeneca’s acquisition of Alexion cleared by European Commission
LONDON, UK: AstraZeneca‘s proposed acquisition of Alexion Pharmaceuticals Inc. has achieved an important step towards completion by having cleared the European Commission review. The clearance follows competition clearances in the United States, Japan and other countries globally, with a complete list available on astrazeneca.com. Regulatory clearance in the UK is pending and remains a requirement to…